Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity

FEMS Microbiol Rev. 2019 Sep 1;43(5):435-456. doi: 10.1093/femsre/fuz012.

Abstract

Approximately 4.4% of the human genome is comprised of endogenous retroviral sequences, a record of an evolutionary battle between man and retroviruses. Much of what we know about viral immunity comes from studies using mouse models. Experiments using the Friend virus (FV) model have been particularly informative in defining highly complex anti-retroviral mechanisms of the intrinsic, innate and adaptive arms of immunity. FV studies have unraveled fundamental principles about how the immune system controls both acute and chronic viral infections. They led to a more complete understanding of retroviral immunity that begins with cellular sensing, production of type I interferons, and the induction of intrinsic restriction factors. Novel mechanisms have been revealed, which demonstrate that these earliest responses affect not only virus replication, but also subsequent innate and adaptive immunity. This review on FV immunity not only surveys the complex host responses to a retroviral infection from acute infection to chronicity, but also highlights the many feedback mechanisms that regulate and counter-regulate the various arms of the immune system. In addition, the discovery of molecular mechanisms of immunity in this model have led to therapeutic interventions with implications for HIV cure and vaccine development.

Keywords: Friend retrovirus; adaptive immunity; immunotherapy; innate immunity; intrinsic immunity; mouse model.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity*
  • Animals
  • Anti-Retroviral Agents / therapeutic use
  • Friend murine leukemia virus / immunology*
  • Host Microbial Interactions / immunology*
  • Humans
  • Immunity, Innate*
  • Immunotherapy
  • Mice
  • Retroviridae Infections / drug therapy
  • Retroviridae Infections / immunology*
  • Retroviridae Infections / therapy

Substances

  • Anti-Retroviral Agents